A Biosimilars Medication Is Very Similar To A Biologic Medication Both Structurally And Functionally

A biosimilar is a replica of a biological molecule that is intended to be comparable to a novel, already approved, and commercially available biological protein medicinal product. The pharmaceutical industry's interest in creating Biosimilars Market goods has significantly increased as a result of the impending expiration of patents on numerous novel biological products and the passage of legislation allowing them to be approved in important geographic areas. The approval criteria and related policy issues have been hotly debated over the past few years among interested parties, including the medical community, patient advocacy organizations, the pharmaceutical industry, and regulatory authorities.

Read more @ https://digitalgrowinfo.blogspot.com/2022/11/biosimilars-are-medications-that-are.html